$81.12
-6.18-7.08%
At close: Dec 16, 4:00 PM EST
$82.00
0.881.08%
After Hours: 5:57 PM EST
Comments
Loading...
Corcept Therapeutics Stock Guidance | NASDAQ:CORT | Benzinga
Corcept Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/04/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $800.00M | $850.00M | $852.50M | Get Alert |
| 07/31/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $850.00M | $900.00M | $899.04M | Get Alert |
| 05/05/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $900.00M | $950.00M | $905.38M | Get Alert |
| 02/26/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $900.00M | $950.00M | $855.08M | Get Alert |
| 10/30/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $675.00M | $700.00M | $661.06M | Get Alert |
| 07/29/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $640.00M | $670.00M | $632.15M | Get Alert |
| 05/01/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $620.00M | $650.00M | $610.64M | Get Alert |
| 02/15/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $531.57M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | Q4 | 2023 | — | — | — | $135.40M | $135.40M | $127.85M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $482.40M | $482.40M | $474.82M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $513.85M | Get Alert |
| 11/01/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $470.00M | $480.00M | $465.62M | Get Alert |
| 08/02/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $455.00M | $470.00M | $443.89M | Get Alert |
| 05/03/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $435.00M | $455.00M | $435.73M | Get Alert |
| 02/28/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $430.00M | $450.00M | $434.79M | Get Alert |
| 11/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $410.00M | $416.67M | Get Alert |
| 08/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $414.43M | Get Alert |
| 05/05/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.85M | Get Alert |
| 02/15/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.19M | Get Alert |
FAQ
Q
What is the most recent guidance for Corcept Therapeutics (CORT)?
A
There have been no specific sales or earnings guidance reported for Corcept Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved